Cargando…
The LIM protein Ajuba recruits DBC1 and CBP/p300 to acetylate ERα and enhances ERα target gene expression in breast cancer cells
Estrogen/ERα signaling is critical for breast cancer progression and therapeutic treatments. Thus, identifying new regulators of this pathway will help to develop new therapeutics to overcome chemotherapy resistance of the breast cancer cells. Here, we report Ajuba directly interacts with ERα to pot...
Autores principales: | Xu, Beihui, Li, Qi, Chen, Ning, Zhu, Chunxiao, Meng, Qingrong, Ayyanathan, Kasirajan, Qian, Wenli, Jia, Hao, Wang, Jiamin, Ni, Peihua, Hou, Zhaoyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412004/ https://www.ncbi.nlm.nih.gov/pubmed/30597111 http://dx.doi.org/10.1093/nar/gky1306 |
Ejemplares similares
-
DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300
por: Kim, Hwa Jin, et al.
Publicado: (2022) -
Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy
por: Ji Yu, Eun, et al.
Publicado: (2011) -
Genome-wide assessment of differential roles for p300 and CBP in transcription regulation
por: Ramos, Yolande F. M., et al.
Publicado: (2010) -
DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers
por: Li, Shanshan, et al.
Publicado: (2018) -
Widespread enhancer activation via ERα mediates estrogen response in vivo during uterine development
por: Jefferson, Wendy N, et al.
Publicado: (2018)